Back to search
MSI Positive Colorectal Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which MSI Positive Colorectal Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which MSI Positive Colorectal Cancer trials you may qualify forThe purpose of this study is to learn about the effects of three study medicines (encorafenib, cetuximab, and pembrolizumab) given together for the treatment of…
The goal of this prospective observational study is to learn more about how a specific type of DNA repair issue-called mismatch repair deficiency (dMMR)-affects…
This is an open-label, parallel group, non-randomized, multicenter phase II study to evaluate the efficacy of spartalizumab (cohorts 1 and 2) and tislelizumab (…